調査レポート | • レポートコード：QYR2104Z0273 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、アルツハイマーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コリンエステラーゼ阻害剤、パイプライン薬、NMDA受容体拮抗薬）、用途別市場規模（病院薬局、小売薬局、オンライン販売）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アルツハイマーの市場動向 ・企業の競争状況、市場シェア ・アルツハイマーの種類別市場規模（コリンエステラーゼ阻害剤、パイプライン薬、NMDA受容体拮抗薬） ・アルツハイマーの用途別市場規模（病院薬局、小売薬局、オンライン販売） ・アルツハイマーの北米市場規模2016-2027（アメリカ、カナダ） ・アルツハイマーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルツハイマーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルツハイマーの中南米市場規模2016-2027（メキシコ、ブラジル） ・アルツハイマーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck） ・結論 |
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer’s disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer’s disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer’swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer’s disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer’s disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer’swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Market Analysis and Insights: Global Alzheimer Market
The global Alzheimer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer market.
Global Alzheimer Scope and Market Size
Alzheimer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Drug Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Drug Type
Cholinesterase inhibitors
Pipeline Drugs
NMDA receptor antagonist
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer Market Size Growth Rate by Drug Type: 2016 VS 2021 VS 2027
1.2.2 Cholinesterase inhibitors
1.2.3 Pipeline Drugs
1.2.4 NMDA receptor antagonist
1.3 Market by Application
1.3.1 Global Alzheimer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer Market Perspective (2016-2027)
2.2 Alzheimer Growth Trends by Regions
2.2.1 Alzheimer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimer Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimer Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimer Industry Dynamic
2.3.1 Alzheimer Market Trends
2.3.2 Alzheimer Market Drivers
2.3.3 Alzheimer Market Challenges
2.3.4 Alzheimer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer Players by Revenue
3.1.1 Global Top Alzheimer Players by Revenue (2016-2021)
3.1.2 Global Alzheimer Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer Revenue
3.4 Global Alzheimer Market Concentration Ratio
3.4.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2020
3.5 Alzheimer Key Players Head office and Area Served
3.6 Key Players Alzheimer Product Solution and Service
3.7 Date of Enter into Alzheimer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer Breakdown Data by Drug Type
4.1 Global Alzheimer Historic Market Size by Drug Type (2016-2021)
4.2 Global Alzheimer Forecasted Market Size by Drug Type (2022-2027)
5 Alzheimer Breakdown Data by Application
5.1 Global Alzheimer Historic Market Size by Application (2016-2021)
5.2 Global Alzheimer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Alzheimer Market Size (2016-2027)
6.2 North America Alzheimer Market Size by Drug Type
6.2.1 North America Alzheimer Market Size by Drug Type (2016-2021)
6.2.2 North America Alzheimer Market Size by Drug Type (2022-2027)
6.2.3 North America Alzheimer Market Size by Drug Type (2016-2027)
6.3 North America Alzheimer Market Size by Application
6.3.1 North America Alzheimer Market Size by Application (2016-2021)
6.3.2 North America Alzheimer Market Size by Application (2022-2027)
6.3.3 North America Alzheimer Market Size by Application (2016-2027)
6.4 North America Alzheimer Market Size by Country
6.4.1 North America Alzheimer Market Size by Country (2016-2021)
6.4.2 North America Alzheimer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Alzheimer Market Size (2016-2027)
7.2 Europe Alzheimer Market Size by Drug Type
7.2.1 Europe Alzheimer Market Size by Drug Type (2016-2021)
7.2.2 Europe Alzheimer Market Size by Drug Type (2022-2027)
7.2.3 Europe Alzheimer Market Size by Drug Type (2016-2027)
7.3 Europe Alzheimer Market Size by Application
7.3.1 Europe Alzheimer Market Size by Application (2016-2021)
7.3.2 Europe Alzheimer Market Size by Application (2022-2027)
7.3.3 Europe Alzheimer Market Size by Application (2016-2027)
7.4 Europe Alzheimer Market Size by Country
7.4.1 Europe Alzheimer Market Size by Country (2016-2021)
7.4.2 Europe Alzheimer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer Market Size (2016-2027)
8.2 Asia-Pacific Alzheimer Market Size by Drug Type
8.2.1 Asia-Pacific Alzheimer Market Size by Drug Type (2016-2021)
8.2.2 Asia-Pacific Alzheimer Market Size by Drug Type (2022-2027)
8.2.3 Asia-Pacific Alzheimer Market Size by Drug Type (2016-2027)
8.3 Asia-Pacific Alzheimer Market Size by Application
8.3.1 Asia-Pacific Alzheimer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimer Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimer Market Size by Region
8.4.1 Asia-Pacific Alzheimer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alzheimer Market Size (2016-2027)
9.2 Latin America Alzheimer Market Size by Drug Type
9.2.1 Latin America Alzheimer Market Size by Drug Type (2016-2021)
9.2.2 Latin America Alzheimer Market Size by Drug Type (2022-2027)
9.2.3 Latin America Alzheimer Market Size by Drug Type (2016-2027)
9.3 Latin America Alzheimer Market Size by Application
9.3.1 Latin America Alzheimer Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimer Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimer Market Size by Application (2016-2027)
9.4 Latin America Alzheimer Market Size by Country
9.4.1 Latin America Alzheimer Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer Market Size (2016-2027)
10.2 Middle East & Africa Alzheimer Market Size by Drug Type
10.2.1 Middle East & Africa Alzheimer Market Size by Drug Type (2016-2021)
10.2.2 Middle East & Africa Alzheimer Market Size by Drug Type (2022-2027)
10.2.3 Middle East & Africa Alzheimer Market Size by Drug Type (2016-2027)
10.3 Middle East & Africa Alzheimer Market Size by Application
10.3.1 Middle East & Africa Alzheimer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimer Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimer Market Size by Country
10.4.1 Middle East & Africa Alzheimer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer Introduction
11.1.4 Allergan Revenue in Alzheimer Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer Introduction
11.2.4 Eisai Revenue in Alzheimer Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer Introduction
11.3.4 Novartis Revenue in Alzheimer Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Alzheimer Introduction
11.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2016-2021)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Details
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Alzheimer Introduction
11.5.4 Merz Pharma Revenue in Alzheimer Business (2016-2021)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer Introduction
11.6.4 Pfizer Revenue in Alzheimer Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Alzheimer Introduction
11.7.4 Johnson & Johnson Revenue in Alzheimer Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Details
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Alzheimer Introduction
11.8.4 Lundbeck Revenue in Alzheimer Business (2016-2021)
11.8.5 Lundbeck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Alzheimer Market Size Growth Rate by Drug Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cholinesterase inhibitors
Table 3. Key Players of Pipeline Drugs
Table 4. Key Players of NMDA receptor antagonist
Table 5. Global Alzheimer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alzheimer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alzheimer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Alzheimer Market Share by Regions (2016-2021)
Table 9. Global Alzheimer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Alzheimer Market Share by Regions (2022-2027)
Table 11. Alzheimer Market Trends
Table 12. Alzheimer Market Drivers
Table 13. Alzheimer Market Challenges
Table 14. Alzheimer Market Restraints
Table 15. Global Alzheimer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Alzheimer Market Share by Players (2016-2021)
Table 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2020)
Table 18. Ranking of Global Top Alzheimer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Alzheimer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimer Product Solution and Service
Table 22. Date of Enter into Alzheimer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 25. Global Alzheimer Revenue Market Share by Drug Type (2016-2021)
Table 26. Global Alzheimer Forecasted Market Size by Drug Type (2022-2027) (US$ Million)
Table 27. Global Alzheimer Revenue Market Share by Drug Type (2022-2027) & (US$ Million)
Table 28. Global Alzheimer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Alzheimer Revenue Market Share by Application (2016-2021)
Table 30. Global Alzheimer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Alzheimer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 33. North America Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million)
Table 34. North America Alzheimer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Alzheimer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Alzheimer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Alzheimer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 39. Europe Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million)
Table 40. Europe Alzheimer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Alzheimer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Alzheimer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Alzheimer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alzheimer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alzheimer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alzheimer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Alzheimer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 51. Latin America Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million)
Table 52. Latin America Alzheimer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Alzheimer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Alzheimer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Alzheimer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Alzheimer Market Size by Drug Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Alzheimer Market Size by Drug Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alzheimer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alzheimer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alzheimer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Alzheimer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Alzheimer Product
Table 65. Allergan Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Eisai Company Details
Table 68. Eisai Business Overview
Table 69. Eisai Alzheimer Product
Table 70. Eisai Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 71. Eisai Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Alzheimer Product
Table 75. Novartis Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Daiichi Sankyo Company Details
Table 78. Daiichi Sankyo Business Overview
Table 79. Daiichi Sankyo Alzheimer Product
Table 80. Daiichi Sankyo Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 81. Daiichi Sankyo Recent Development
Table 82. Merz Pharma Company Details
Table 83. Merz Pharma Business Overview
Table 84. Merz Pharma Alzheimer Product
Table 85. Merz Pharma Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 86. Merz Pharma Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Alzheimer Product
Table 90. Pfizer Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Alzheimer Product
Table 95. Johnson & Johnson Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Lundbeck Company Details
Table 98. Lundbeck Business Overview
Table 99. Lundbeck Revenue in Alzheimer Business (2016-2021) & (US$ Million)
Table 100. Lundbeck Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Market Share by Drug Type: 2020 VS 2027
Figure 2. Cholinesterase inhibitors Features
Figure 3. Pipeline Drugs Features
Figure 4. NMDA receptor antagonist Features
Figure 5. Global Alzheimer Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Sales Case Studies
Figure 9. Alzheimer Report Years Considered
Figure 10. Global Alzheimer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Alzheimer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Alzheimer Market Share by Regions: 2020 VS 2027
Figure 13. Global Alzheimer Market Share by Regions (2022-2027)
Figure 14. Global Alzheimer Market Share by Players in 2020
Figure 15. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2020
Figure 17. Global Alzheimer Revenue Market Share by Drug Type (2016-2021)
Figure 18. Global Alzheimer Revenue Market Share by Drug Type (2022-2027)
Figure 19. North America Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Alzheimer Market Share by Drug Type (2016-2027)
Figure 21. North America Alzheimer Market Share by Application (2016-2027)
Figure 22. North America Alzheimer Market Share by Country (2016-2027)
Figure 23. United States Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Alzheimer Market Share by Drug Type (2016-2027)
Figure 27. Europe Alzheimer Market Share by Application (2016-2027)
Figure 28. Europe Alzheimer Market Share by Country (2016-2027)
Figure 29. Germany Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Alzheimer Market Share by Drug Type (2016-2027)
Figure 37. Asia-Pacific Alzheimer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Alzheimer Market Share by Region (2016-2027)
Figure 39. China Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Alzheimer Market Share by Drug Type (2016-2027)
Figure 47. Latin America Alzheimer Market Share by Application (2016-2027)
Figure 48. Latin America Alzheimer Market Share by Country (2016-2027)
Figure 49. Mexico Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Alzheimer Market Share by Drug Type (2016-2027)
Figure 53. Middle East & Africa Alzheimer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Alzheimer Market Share by Country (2016-2027)
Figure 55. Turkey Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Alzheimer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 59. Eisai Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 61. Daiichi Sankyo Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 62. Merz Pharma Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 65. Lundbeck Revenue Growth Rate in Alzheimer Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のアルツハイマー病用パイプライン薬市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Pipeline Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 世界のアルツハイマー病治療薬市場 2021：企業別、地域別、種類・用途別 The Alzheimer’s Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Market Analysis and Insights: Glob…
- 世界のアルツハイマー病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…